Sung-nam C. Lim
Haeundae, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Response kinetics as a dynamic prognostic marker in patients with multiple myeloma.
Journal: Leukemia
Published: August 24, 2025
Survival Benefits of Early Treatment With Blinatumomab in Adult Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 24, 2025
Anti-HER2/Neu Antibody Therapy Inhibits HER2+ Breast Cancer by Blocking Myeloid-Derived Suppressor Cell Activity.
Journal: Oncology research and treatment
Published: June 11, 2025
Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 09, 2025
Correction: Evidence‑based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions.
Journal: Blood research
Published: April 08, 2025
Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia.
Journal: International journal of hematology
Published: February 04, 2025
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials.
Journal: Leukemia research
Published: April 13, 2024
Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913).
Journal: Cancer research and treatment
Published: January 21, 2024
Last Updated: 09/26/2026